Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents

详细信息    查看全文

• 作者：Amy L. Cole^a ; Sandra Hossain^b ; Alex M. Cole^a ; Otto Phanstiel IV^b ; ^{otto.phanstiel@ucf.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：HIV-1 ; human immunodeficiency virus-1 ; AIDS ; acquired immunodeficiency syndrome ; ART ; antiretroviral therapy ; HCMV ; human cytomegalovirus ; CHO ; Chinese hamster ovary ; TCID50 ; tissue culture infectious dose ; i.e. ; the dose that resulted in infection of 50% of the cells in culture ; MOI ; multiplicity of infection ; DMSO ; dimethylsulfoxide
• 刊名：Bioorganic & Medicinal Chemistry
• 出版年：2016
• 出版时间：15 June 2016
• 年：2016
• 卷：24
• 期：12
• 页码：2768-2776
• 全文大小：931 K

文摘

A series of chalcone, flavone, coumaranone and other flavonoid compounds were screened for their anti HIV-1 activity in two cell culture models using TZM-bl and PM1 cells. Within the systems evaluated, the most promising compounds contained either an α- or β-hydroxy-carbonyl motif within their structure (e.g., 8 and 9). Efficacious substituents were identified and used to design new HIV inhibitors with increased potency and lower cytotoxicity. Of the scaffolds evaluated, specific chalcones were found to provide the best balance between anti-HIV potency and low host cell toxicity. Chalcone 8l was shown to inhibit different clinical isolates of HIV in a dose-dependent manner (e.g., IC₅₀ typically ⩽ 5 μM). Inhibition of HIV infection experiments using TZM-bl cells demonstrated that chalcone 8l and flavonol 9c had IC₅₀ values of 4.7 μM and 10.4 μM, respectively. These insights were used to design new chalcones 8o and 8p. Rewardingly, chalcones 8o and 8p (at 10 μM) each gave >92% inhibition of viral propagation without impacting PM1 host cell viability. Inhibition of viral propagation significantly increased (60–90%) when PM1 cells were pre-incubated with chalcone 8o, but not with the related flavonol 9c. These results suggested that chalcone 8o may be of value as both a HIV prophylactic and therapy. In summary, O-benzyl-substituted chalcones were identified as promising anti-HIV agents for future investigation.